Chartsonlygoup's future update (it'll live): tomwong.xyz/stock-status/

  Celgene Corp. ( CELG ) |
2007 - 2021 (13 years)

Net Revenue (Sales) is 
$17.5B (1Y +10.2% )

CELG Stock Price & Net Revenue (Sales)

Net Revenue (Sales) for CELG competitors.
AMGN ALXN GILD ILMN BIIB JNJ LLY EPZM OMED
Note: Stonk = Stock. Both words are used interchangeably. 🙂

Historical (All-Time) Stats for Net Revenue (Sales)

chevron_right 2019 $17.0B +23.3x
( +27.8% / year avg)
chevron_left 2007 $697.8M
vertical_align_top Peak $17.0B +23.3x
vertical_align_bottom Bottom $697.8M
arrow_drop_up # Up Years 12 12 of 13
years up.
arrow_drop_down # Down Years 1
Up Years = Positive (0%+) YoY change
Down Years = Zero or Negative (0% or less) YoY change

Key Points (Stonk Price Comparison)

  • CELG's stock price has rallied +30,825% from $0.35 in 2007 , or +13.2x faster than it's net revenue (sales) over the same period.
  • If CELG grows it's stock at the same rate as it's net revenue (sales) (+27.8%/year) , it's stock price will grow +1,162% and hit $1258.05 over the next 10 years.
  • CELG's stock price has gone up 7 of the 12 years (+58%) it's net revenue (sales) were also up.
  • Line Item (in $M) FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008
    1 Revenue 15281000000 13003000000 11229200000 9256000000 7670400000 6493900000 5506713000 4842070000 3625745000 2689893000 2254781000
    2 Cost of Revenue 587000000 461000000 438000000 420100000 385900000 340400000 299124000 425859000 306521000 216289000 258267000
    3 Gross Profit (Income) 14678000000 12512000000 10746600000 8741000000 7177900000 6021900000 5086475000 4273831000 3201917000 2473604000 1996514000
    4 R&D 5673000000 5915000000 4470100000 3697300000 2430600000 2226200000 1724156000 1600264000 1128495000 794848000 931218000
    5 SG&A 3250000000 2941000000 2657700000 2305400000 2027900000 1684500000 1373541000 1226314000 950634000 753827000 685547000
    6 Other Expenses 337000000.00 24000000.00 -324000000.00 48000000.00 -43000000.00 -73000000.00 -17006000.00 -3550000.00 -7220000.00 60461000.00 24722000.00
    7 Operating Expenses 8923000000 8856000000 7127800000 6002700000 4458500000 3910700000 3097697000 2826578000 2079129000 1548675000 1616765000
    8 Interest Expense 741000000.00 522000000.00 500100000.00 310600000.00 176100000.00 91600000.00 63205000.00 42737000.00 12634000.00 -1966000.00 -4437000.00
    9 D&A 635000000 471000000 504700000 408900000 373600000 374100000 284891000 379593000 259089000 41682000 44536000
    10 EBITDA 5826000000 5178000000 3671300000 2663500000 2892600000 2183000000 2031333000 1822346000 1248724000 883208000 -1419682000
    11 Operating Income 5191000000 4707000000 3166600000 2254600000 2519000000 1808900000 1746442000 1442753000 989635000 841526000 -1464218000
    12 Other Income Expenses (Net) 337000000.00 24000000.00 -324000000.00 48000000.00 -43000000.00 -73000000.00 -17006000.00 -3550000.00 -7220000.00 60461000.00 24722000.00
    13 Pre-Income Tax 4832000000 4314000000 2372500000 2023500000 2327400000 1665400000 1681491000 1419522000 1012930000 975703000 -1368825000
    14 Income Tax Expense 786000000 1374000000 373300000 421500000 327500000 215500000 225311000 102066000 132418000 198956000 164828000
    15 Net Income 4046000000 2940000000 1999200000 1602000000 1999900000 1449900000 1456180000 1318150000 880512000 776747000 -1533653000
    16 EPS 5.65 3.77 2.57 2.02 2.49 3.50 3.38 2.89 1.90 1.69 -3.46
    17 EPS Diluted 5.51 3.64 2.49 1.94 2.39 3.37 3.30 2.85 1.88 1.66 -3.46
    18 Shares Outstanding 716300000 779200000 777200000 792200000 802700000 413800000 430927000 455348000 462298000 459304000 442620000
    19 Shares Outstanding (Diluted) 733800000 808700000 803300000 824900000 836000000 430300000 440796000 462748000 469517000 467354000 442620000
  • Line Item (in $M) FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008
    1 Cash & Cash Equivalents 4234000000 7013000000 6169900000 4880300000 4121600000 3234400000 2090387000 1859464000 1351128000 1102172000 1092386000
    2 Short Term Investments 496000000 5029000000 1799800000 1671600000 3425100000 2452600000 1809883000 788690000 1250173000 1894580000 1129705000
    3 Cash & S-T Investments 4730000000 12042000000 7969700000 6551900000 7546700000 5687000000 3900270000 2648154000 2601301000 2996752000 2222091000
    4 Accounts Receivables 2066000000 1921000000 1620600000 1420900000 1166700000 1061400000 960521000 945531000 706429000 438617000 312243000
    5 Inventory 458000000 541000000 497900000 443400000 393100000 340400000 259495000 189573000 260130000 100683000 100176000
    6 Other Current Assets 1813000000 388000000 779300000 984700000 606100000 461700000 413379000 569967000 775339000 308752000 206856000
    7 Total Current Assets 9067000000 14892000000 10867500000 9400900000 9712600000 7550500000 5533665000 4353225000 4343199000 3844804000 2841366000
    8 PP&E 1367000000 1070000000 929800000 814100000 642600000 593400000 578362000 506042000 509919000 297792000 248971000
    9 Goodwill 8003000000 4866000000 4865800000 4879000000 2191200000 2041200000 2042773000 1887220000 1896344000 578116000 588822000
    10 Intangible Assets 16213000000 8436000000 10391800000 10858100000 4067600000 2839700000 3100423000 2844698000 3248498000 349542000 434764000
    11 Goodwill & Intangible Assets 24216000000 13302000000 15257600000 15737100000 6258800000 4880900000 5143196000 4731918000 5144842000 927658000 1023586000
    12 L-T Investments 0.00 5029000000.00 1799000000.00 1671000000.00 3425000000.00 2452000000.00 1809883000.00 788690000.00 23073000.00 1894580000.00 1129705000.00
    13 Tax Assets 24000000.00 23000000.00 137700000.00 65600000.00 11700000.00 25300000.00 93168000.00 116751000.00 151779000.00 0.00 0.00
    14 Other Non-Current Assets 806000000.00 854000000.00 893000000.00 1035700000.00 714400000.00 328100000.00 385915000.00 297974000.00 4350000.00 0.00 0.00
    15 Total Non-Current Assets 26413000000 15249000000 17218100000 17652500000 7627500000 5827700000 6200641000 5652685000 5833963000 1544507000 1603904000
    16 Other Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    17 Total Assets 35480000000 30141000000 28085600000 27053400000 17340100000 13378200000 11734306000 10005910000 10177162000 5389311000 4445270000
    18 Accounts Payables 418000000 305000000 247100000 240800000 198200000 156200000 145652000 121525000 94465000 36629000 53859000
    19 S-T Debt 501000000.00 0.00 500700000.00 0.00 605900000.00 544800000.00 308459000.00 526684000.00 309214000.00 0.00 0.00
    20 Income Tax Payables 78000000.00 84000000.00 41300000.00 19800000.00 12700000.00 16000000.00 11841000.00 30042000.00 11423000.00 46874000.00 51162000.00
    21 Deferred Revenue 73000000 75000000 55100000 60600000 28500000 27700000 17263000 14346000 16362000 49817000 16415000
    22 Other Current Liabilities 2987000000 2523000000 2115000000 1647700000 1266900000 1200800000 1207020000 847375000 638918000 408259000 456974000
    23 Total Current Liabilities 4057000000 2987000000 2959200000 1968900000 2112200000 1945500000 1690235000 1539972000 1070382000 494705000 527248000
    24 L-T Debt 19769000000 15838000000 13788500000 14250400000 6265700000 4196500000 2771333000 1275585000 1247584000 315608000 306120000
  • Line Item (in $M) FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008
    1 Net Income (Earnings) 4046000000 2940000000 1999200000 1602000000 1999900000 1449900000 1456180000 1318150000 880512000 776747000 -1533653000
    2 D&A 635000000 471000000 504700000 408900000 373600000 374100000 284891000 379593000 259089000 41682000 44536000
    3 Deferred Income Tax -32000000 1330000000 344000000 33400000 272300000 246600000 -100199000 85822000 103923000 -26939000 -104588000
    4 Stock-Based Compensation (SBC) 921000000 644000000 606200000 576600000 447600000 325800000 231043000 225154000 186989000 145929000 106578000
    5 Change in Working Capital -6895000000.00 3996700000.00 476300000.00 -168400000.00 1995400000.00 1761570000.00 1030177000.00 -459564000.00 -77282000.00 1035981000.00 -337372000.00
    6 Accounts Receivables -178000000.00 -236000000.00 -222400000.00 -304700000.00 -166300000.00 -101400000.00 -30052000.00 -263130000.00 -234452000.00 2664000.00 6232000.00
    7 Inventory 82000000.00 -42000000.00 -55300000.00 -50600000.00 -56500000.00 -89700000.00 -69680000.00 70980000.00 18723000.00 1540000.00 -25867000.00
    8 Accounts Payables 290000000.00 273000000.00 618900000.00 533000000.00 252300000.00 287200000.00 68191000.00 223814000.00 51557000.00 652000.00 -15572000.00
    9 Other Working Capital 5010000000 11905000000 7908300000 7432000000 7600400000 5605000000 3843430000 2813253000 3272817000 3350099000 2314118000
    10 Other Non-Cash Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    11 Net Cash Provided by Operating Activities 5171000000 5246000000 3976300000 2483900000 2806300000 2225900000 2018553000 1808685000 1181556000 909855000 182187000
    12 Investments in PP&E -330000000.00 -279000000.00 -236200000.00 -286300000.00 -150300000.00 -119700000.00 -111524000.00 -132119000.00 -98632000.00 0.00 0.00
    13 Acquisitions (Net) -8648000000.00 0.00 0.00 -7695100000.00 -710000000.00 0.00 -352245000.00 0.00 -2652377000.00 0.00 -746779000.00
    14 Purchase of Investments -7020000000 -3928000000 -2292300000 -3529300000 -3042500000 -2764600000 -2073616000 -2280405000 -3469361000 -3007673000 -835967000
    15 Sales/Maturities of Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 3931883000.00 0.00 0.00
    16 Other Investing Activities 9580000000.00 1316000000.00 1526300000.00 5251700000.00 2464800000.00 4446500000.00 983793000.00 2790220000.00 181182000.00 0.00 0.00
    17 Net Cash used for Investing Activities -6418000000 -2891000000 -1002200000 -6259000000 -1438000000 1562200000 -1553592000 377696000 -2107305000 -856078000 -522246000
    18 Debt Repayment 0.00 -1904000000.00 0.00 -513900000.00 -3012200000.00 -4227900000.00 -4712174000.00 -1353061000.00 121976000.00 0.00 0.00
    19 Common Stock Issued 0.00 0.00 7000000.00 -8000000.00 10000000.00 1000000.00 476228000.00 166451000.00 86889000.00 49751000.00 128583000.00
    20 Common Stock Repurchased -6096000000.00 -3833000000.00 -2160000000.00 -3256800000.00 -2975100000.00 -2764600000.00 -2043570000.00 -2221157000.00 -183116000.00 0.00 0.00
    21 Dividends Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    22 Other Financing Activities 4556000000.00 4153000000.00 514400000.00 8355200000.00 5569900000.00 6438800000.00 6507016000.00 1919613000.00 1360283000.00 0.00 0.00
    23 Net Cash Used Provided by Financing Activities -1540000000 -1584000000 -1645600000 4584500000 -417400000 -553700000 -248728000 -1654605000 1177167000 -61872000 281629000
    24 Net Change in Cash -2779000000.00 843000000.00 1289600000.00 758700000.00 4121600000.00 3234400000.00 2090387000.00 1859464000.00 248956000.00 9786000.00 -125887000.00
  • About
    Industry: Biotechnology
    Sector: Healthcare
    Country: nan
    IPO Date: nan
    Stonk Exchange: NASDAQ
    • nan